Skip to main content
Tech.euFundingExplorerBeta

Citryll

Citryll is a Targeting Neutrophil Extracellular Traps

Total raised
€119M
€118,500,000
Funding rounds
3
Investors
9
distinct backers
Active since
2019-06
latest 2024-12

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood59
base rate 48% for Series B
  • In typical raise window
  • Up-round momentum
  • Low backer re-investment
Exit likelihood24
base rate 12% (2+ rounds)
  • 3 rounds raised
  • €100M+ raised
  • 7y since founding

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds
DateStageAmountInvestors
2024-12-10Series B€85MBioGeneration Ventures,BOM,Citryll’s founders,Curie Capital,Forbion,Johnson & Johnson+3 moreView deal →
2020-02-07Other€19MBioGeneration Ventures,Seventure PartnersView deal →
2019-07-01Series A€15MView deal →

Similar companies

same sector or country